Emory to conduct H1N1 vaccine trial in asthma sufferers

Emory University will participate in a clinical trial to study what dose of the 2009 H1N1 vaccine is needed to build up an effective immunity in people with asthma, particularly those with severe cases of the respiratory disease.

People with underlying conditions, such as asthma, are at greater risk of developing complications from the disease. The trials will be conducted at Emory and six other sites that participate in the NHLBI's Severe Asthma Research Program. At Emory, the program is through the Emory-Children's Center, which is jointly run by Emory and Children's Healthcare of Atlanta.